Synopsis of recent research by authors named "Qingyuan Meng"
- Qingyuan Meng's recent research primarily focuses on the development and evaluation of novel pharmacological agents, including kappa opioid receptor agonists and inhibitors targeting specific kinases for cancer treatment.
- Key findings include the promising assessment of HSK21542, a peripherally-restricted kappa opioid receptor agonist, indicating a low abuse potential and development of HPK1 inhibitors which enhance immunotherapy efficacy against cancer.
- Additionally, Meng's work explores advanced imaging techniques, notably the clinical performance of deep learning-enhanced scintigraphy for detecting malignancies, potentially improving diagnostic accuracy and efficiency in medical imaging.
